Covidien Announces FDA Approval For Its Generic Myocardial Perfusion Imaging Kit (Medical News Today)
Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Company's Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection.

Glenmark receives US FDA approval for Betamethasone cream (PharmaBiz)
Glenmark Generics Limited's (GGL) US subsidiary has received ANDA approval from the United States Food and Drug Administration (US FDA) for Betamethasone dipropionate cream, 0.05 per cent (augmented) and will soon commence marketing and distribution of this product in the US market.